Bausch & Lomb (BLCO) Interest & Investment Income (2022 - 2026)
Bausch & Lomb's (BLCO) quarterly Interest & Investment Income came in at $4.0 million in Q2 2026, up 33.33% YoY from $3.0 million in Q2 2025, and little changed on a QoQ basis from $4.0 million in Q1 2026.
Bausch & Lomb (BLCO) Interest & Investment Income (2022 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 5 years of Interest & Investment Income data on file, last reported at $4.0 million in Q2 2026.
- Quarterly Interest & Investment Income rose 33.33% year-over-year to $4.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $14.0 million (down 6.67% YoY) and the FY2025 annual result came in at $12.0 million, down 20.0% from the prior year.
- Interest & Investment Income was little changed at $4.0 million in Q2 2026, from $4.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $5.0 million in Q2 2023 to a low of $1.0 million in Q2 2022.
- A 5-year average of $3.3 million and a median of $3.0 million in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 400.0% — and 2024, when it plunged 40.0%.
- Tracing BLCO's Interest & Investment Income over 5 years: stood at $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then soared by 66.67% to $5.0 million in 2024, then sank by 40.0% to $3.0 million in 2025, then jumped by 33.33% to $4.0 million in 2026.
- The last three Interest & Investment Income figures came in at $4.0 million (Q2 2026), $4.0 million (Q1 2026), and $3.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 4.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 20.89 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 3.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -64.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -64.00 Mn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 1.00 Mn |